Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$5.0M
Filings
96
Firms Hired
3
Active Period
2005–2024
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
To amend the Public Health Service Act to require the development of a diagnostic testing preparedness plan to be used during public health emergencies, and for other purposes.
2024 · third_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to diagnostic testing and reimbursement. Issues related to the Strategic National Stockpile, supply chain, and future pandemic preparedness PREVENT Pandemics Act FY 2024 Appropriations PASTEUR ACT/ Issues related to antimicrobial resistance Issues related to adoption of PLA codes Pandemic and All-Hazards Preparedness Act Reauthorization H.R. 3795 To amend the Public Health Service Act issues related to hepatitis-C including HEP-C testing
Client expense: — · Firm income: $20,000
Matched citations: H.R. 3795
To amend the Public Health Service Act to require the development of a diagnostic testing preparedness plan to be used during public health emergencies, and for other purposes.
2024 · second_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to diagnostic testing and reimbursement. Issues related to the Strategic National Stockpile, supply chain, and future pandemic preparedness PREVENT Pandemics Act FY 2024 Appropriations PASTEUR ACT/ Issues related to antimicrobial resistance Issues related to adoption of PLA codes Pandemic and All-Hazards Preparedness Act Reauthorization H.R. 3795 To amend the Public Health Service Act Alzheimer's testing issues related to hepatitis-C including HEP-C testing
Client expense: — · Firm income: $60,000
Matched citations: H.R. 3795
To amend the Public Health Service Act to require the development of a diagnostic testing preparedness plan to be used during public health emergencies, and for other purposes.
2024 · first_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to diagnostic testing and reimbursement related to COVID testing Issues related to the Strategic National Stockpile, supply chain, and future pandemic preparedness PREVENT Pandemics Act FY 2024 Appropriations PASTEUR ACT/ Issues related to antimicrobial resistance Issues related to adoption of PLA codes Pandemic and All-Hazards Preparedness Act Reauthorization H.R. 3795 To amend the Public Health Service Act Alzheimer's testing Tuberculosis testing
Client expense: — · Firm income: $70,000
Matched citations: H.R. 3795
Preparing for All Hazards and Pathogens Reauthorization Act
2023 · fourth_quarter · Firm: Cepheid
Issues related to diagnostic testing; issues related to Antimicrobial Resistance; issues related to H.R. 4421/S.2333, the Pandemic All Hazards Preparedness Act (PAHPA) reauthorization; issues related to Hepatitis C funding.
Client expense: $200,000 · Firm income: —
Matched citations: H.R. 4421
Pandemic and All-Hazards Preparedness and Response Act
2023 · fourth_quarter · Firm: Cepheid
Issues related to diagnostic testing; issues related to Antimicrobial Resistance; issues related to H.R. 4421/S.2333, the Pandemic All Hazards Preparedness Act (PAHPA) reauthorization; issues related to Hepatitis C funding.
Client expense: $200,000 · Firm income: —
Matched citations: S.2333
To amend the Public Health Service Act to require the development of a diagnostic testing preparedness plan to be used during public health emergencies, and for other purposes.
2023 · fourth_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to diagnostic testing and reimbursement related to COVID testing Issues related to the Strategic National Stockpile, supply chain, and future pandemic preparedness PREVENT Pandemics Act FY 2024 Appropriations PASTEUR ACT/ Issues related to antimicrobial resistance Issues related to adoption of PLA codes Pandemic and All-Hazards Preparedness Act Reauthorization H.R. 3795 To amend the Public Health Service Act Alzheimer's testing
Client expense: — · Firm income: $60,000
Matched citations: H.R. 3795
Preparing for All Hazards and Pathogens Reauthorization Act
2023 · third_quarter · Firm: Cepheid
Issues related to diagnostic testing; issues related to Antimicrobial Resistance; issues related to H.R. 4421/S.2333, the Pandemic All Hazards Preparedness Act (PAHPA) reauthorization; issues related to Hepatitis C funding.
Client expense: $200,000 · Firm income: —
Matched citations: H.R. 4421
Pandemic and All-Hazards Preparedness and Response Act
2023 · third_quarter · Firm: Cepheid
Issues related to diagnostic testing; issues related to Antimicrobial Resistance; issues related to H.R. 4421/S.2333, the Pandemic All Hazards Preparedness Act (PAHPA) reauthorization; issues related to Hepatitis C funding.
Client expense: $200,000 · Firm income: —
Matched citations: S.2333
To amend the Public Health Service Act to require the development of a diagnostic testing preparedness plan to be used during public health emergencies, and for other purposes.
2023 · third_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to diagnostic testing and reimbursement related to COVID testing. Issues related to the Strategic National Stockpile, supply chain, and future pandemic preparedness. PREVENT Pandemics Act FY 2024 Appropriations PASTEUR ACT/ Issues related to antimicrobial resistance. Issues related to adoption of PLA codes. Pandemic and All-Hazards Preparedness Act Reauthorization H.R. 3795 To amend the Public Health Service Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 3795
Issues related to diagnostic testing; issues related to Antimicrobial Resistance; issues related to H.R. 4221, the Pandemic All Hazards Preparedness Act (PAHPA) reauthorization; issues related to S.1355, the Pasteur Act; issues related to Hepatitis C funding.
Client expense: $200,000 · Firm income: —
Matched citations: H.R. 4221
Issues related to diagnostic testing; issues related to Antimicrobial Resistance; issues related to H.R. 4221, the Pandemic All Hazards Preparedness Act (PAHPA) reauthorization; issues related to S.1355, the Pasteur Act; issues related to Hepatitis C funding.
Client expense: $200,000 · Firm income: —
Matched citations: S.1355
To amend the Public Health Service Act to require the development of a diagnostic testing preparedness plan to be used during public health emergencies, and for other purposes.
2023 · second_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to COVID-19 Issues related to diagnostic testing and reimbursement related to COVID testing Issues related to the Strategic National Stockpile, supply chain, and future pandemic preparedness PREVENT Pandemics Act FY 2023 Appropriations PASTEUR ACT/ Issues related to antimicrobial resistance Issues related to adoption of PLA codes Pandemic and All-Hazards Preparedness Act Reauthorization H.R. 3795 To amend the Public Health Service Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 3795
issues related to diagnostic testing, issues related to responding to the current COVID-19 pandemic and future pandemics; S. 2209/H.R. 4128, the Verifying Accurate Leading-Edge IVCT Development Act of 2021 (VALID); S. 3799 the PREVENT Pandemics Act; H.R. 6851, No Surprises for COVID-19 Tests Act.
Client expense: $140,000 · Firm income: —
Matched citations: H.R. 4128
issues related to diagnostic testing, issues related to responding to the current COVID-19 pandemic and future pandemics; S. 2209/H.R. 4128, the Verifying Accurate Leading-Edge IVCT Development Act of 2021 (VALID); S. 3799 the PREVENT Pandemics Act; H.R. 6851, No Surprises for COVID-19 Tests Act.
Client expense: $140,000 · Firm income: —
Matched citations: H.R. 6851
issues related to diagnostic testing, issues related to responding to the current COVID-19 pandemic and future pandemics; S. 2209/H.R. 4128, the Verifying Accurate Leading-Edge IVCT Development Act of 2021 (VALID); S. 3799 the PREVENT Pandemics Act; H.R. 6851, No Surprises for COVID-19 Tests Act.
Client expense: $140,000 · Firm income: —
Matched citations: S. 2209
issues related to diagnostic testing, issues related to responding to the current COVID-19 pandemic and future pandemics; S. 2209/H.R. 4128, the Verifying Accurate Leading-Edge IVCT Development Act of 2021 (VALID); S. 3799 the PREVENT Pandemics Act; H.R. 6851, No Surprises for COVID-19 Tests Act.
Client expense: $140,000 · Firm income: —
Matched citations: S. 3799
VALID Act of 2021
2022 · fourth_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to COVID-19 - American Rescue Plan Implementation Issues related to diagnostic testing and reimbursement related to COVID testing Issues related to the Strategic National Stockpile, supply chain, and future pandemic preparedness S.2209/H.R.4128 - VALID Act of 2021 S.3799 - PREVENT Pandemics Act FY 2023 Appropriations
Client expense: — · Firm income: $60,000
Matched citations: H.R.4128
VALID Act of 2021
2022 · fourth_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to COVID-19 - American Rescue Plan Implementation Issues related to diagnostic testing and reimbursement related to COVID testing Issues related to the Strategic National Stockpile, supply chain, and future pandemic preparedness S.2209/H.R.4128 - VALID Act of 2021 S.3799 - PREVENT Pandemics Act FY 2023 Appropriations
Client expense: — · Firm income: $60,000
Matched citations: S.2209
PREVENT Pandemics Act
2022 · fourth_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to COVID-19 - American Rescue Plan Implementation Issues related to diagnostic testing and reimbursement related to COVID testing Issues related to the Strategic National Stockpile, supply chain, and future pandemic preparedness S.2209/H.R.4128 - VALID Act of 2021 S.3799 - PREVENT Pandemics Act FY 2023 Appropriations
Client expense: — · Firm income: $60,000
Matched citations: S.3799
issues related to diagnostic testing, issues related to responding to the current COVID-19 pandemic and future pandemics; S. 2209/H.R. 4128, the Verifying Accurate Leading-Edge IVCT Development Act of 2021 (VALID); S. 3799 the PREVENT Pandemics Act; H.R. 6851, No Surprises for COVID-19 Tests Act.
Client expense: $140,000 · Firm income: —
Matched citations: H.R. 4128
issues related to diagnostic testing, issues related to responding to the current COVID-19 pandemic and future pandemics; S. 2209/H.R. 4128, the Verifying Accurate Leading-Edge IVCT Development Act of 2021 (VALID); S. 3799 the PREVENT Pandemics Act; H.R. 6851, No Surprises for COVID-19 Tests Act.
Client expense: $140,000 · Firm income: —
Matched citations: H.R. 6851
issues related to diagnostic testing, issues related to responding to the current COVID-19 pandemic and future pandemics; S. 2209/H.R. 4128, the Verifying Accurate Leading-Edge IVCT Development Act of 2021 (VALID); S. 3799 the PREVENT Pandemics Act; H.R. 6851, No Surprises for COVID-19 Tests Act.
Client expense: $140,000 · Firm income: —
Matched citations: S. 2209
issues related to diagnostic testing, issues related to responding to the current COVID-19 pandemic and future pandemics; S. 2209/H.R. 4128, the Verifying Accurate Leading-Edge IVCT Development Act of 2021 (VALID); S. 3799 the PREVENT Pandemics Act; H.R. 6851, No Surprises for COVID-19 Tests Act.
Client expense: $140,000 · Firm income: —
Matched citations: S. 3799
VALID Act of 2021
2022 · third_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to COVID-19 - American Rescue Plan Implementation Issues related to diagnostic testing and reimbursement related to COVID testing Issues related to the Strategic National Stockpile, supply chain, and future pandemic preparedness S.2209/H.R.4128 - VALID Act of 2021 S.3799 - PREVENT Pandemics Act
Client expense: — · Firm income: $60,000
Matched citations: H.R.4128
VALID Act of 2021
2022 · third_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to COVID-19 - American Rescue Plan Implementation Issues related to diagnostic testing and reimbursement related to COVID testing Issues related to the Strategic National Stockpile, supply chain, and future pandemic preparedness S.2209/H.R.4128 - VALID Act of 2021 S.3799 - PREVENT Pandemics Act
Client expense: — · Firm income: $60,000
Matched citations: S.2209
Source: Senate LDA